INHIBRX BIOSCIENCES, INC. (INBX) FY2026 YTD Q2 Statement of Cash Flows

Statement of Cash Flows

2026-01-01 to 2026-06-30

Swipe to see the full flow
INHIBRX BIOSCIENCES, INC. cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Proceeds from the issuance of debt → financing reconciliation: $74,992,000.00Proceeds from the exercise of stock options → financing reconciliation: $2,075,000.00financing reconciliation → Net cash from financing activities: $77,067,000.00Net cash used in operating activities → operating reconciliation: $67,943,000.00Stock-based compensation expense → operating reconciliation: $5,757,000.00Accounts payable → operating reconciliation: $3,829,000.00Accretion of debt discount and non-cash interest expense → operating reconciliation: $2,023,000.00Depreciation and amortization → operating reconciliation: $1,060,000.00Non-cash lease expense → operating reconciliation: $980,000.00Other receivables → operating reconciliation: $45,000.00Loss on disposal of fixed assets → operating reconciliation: $14,000.00operating reconciliation → Net loss: $70,091,000.00operating reconciliation → Accrued expenses: $9,756,000.00operating reconciliation → Operating lease liability: $1,112,000.00operating reconciliation → Prepaid expenses and other current assets: $692,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $124,220,000.00Net cash from financing activities → Cash sources and uses: $77,067,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $133,344,000.00Cash sources and uses → Net cash used in operating activities: $67,943,000.00Net loss: -$70,091,000.00Net loss−$70.09 MDepreciation and amortization: $1,060,000.00Depreciation & amortization+$1.06 MAccretion of debt discount and non-cash interest expense: $2,023,000.00Debt cost amortization+$2.02 MStock-based compensation expense: $5,757,000.00Stock-based compensation+$5.76 MNon-cash lease expense: $980,000.00Non-cash lease expense+$980.00 KLoss on disposal of fixed assets: $14,000.00PP&E disposal gain & loss+$14.00 KAccounts receivable: $0.00Other receivables: $45,000.00Other receivables+$45.00 KReceivables from related parties: $0.00Prepaid expenses and other current assets: -$692,000.00Prepaid & other assets−$692.00 KOther non-current assets: $0.00Accounts payable: $3,829,000.00Accounts payable+$3.83 MAccrued expenses: -$9,756,000.00Accrued liabilities−$9.76 MOperating lease liability: -$1,112,000.00Operating lease liabilities−$1.11 MNet cash used in operating activities: -$67,943,000.00. Cash required to fund net payments.Operating cash−$67.94 Moperating reconciliation: $81,651,000.00Proceeds from the issuance of debt: $74,992,000.00Secured debt issued+$74.99 MPayment of fees associated with debt: $0.00Proceeds from the exercise of stock options: $2,075,000.00Stock option exercises+$2.08 MNet cash from financing activities: $77,067,000.00Financing cash+$77.07 Mfinancing reconciliation: $77,067,000.00Purchase of property and equipment: $0.00Net cash from investing activities: $0.00Investing cash$0.00investing reconciliation: $0.00Cash sources and uses: $201,287,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $124,220,000.00Beginning cash$124.22 MEnding cash: Cash, cash equivalents, and restricted cash: $133,344,000.00Ending cash$133.34 MCASH RECONCILIATIONFinancingflowsInvestingflowsOperatingflowsNet loss −$70.09M + net operating adjustments $2.15M = operating cash −$67.94MFree cash flow−$67.94 MOperating cash − cash spent on PP&ECash flow / Net incomeNot meaningfulOperating cash flow ÷ net incomeNet cash change+$9.12 MEnding cash − beginning cash
Chart details

INHIBRX BIOSCIENCES, INC. cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026

Cash flows for Jan 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 31, 2025. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Dec 31, 2025
124,220,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
negative 67,943,000 US dollars. Net cash used.
Net loss
negative 70,091,000 US dollars
Depreciation and amortization
1,060,000 US dollars
Accretion of debt discount and non-cash interest expense
2,023,000 US dollars
Stock-based compensation expense
5,757,000 US dollars
Non-cash lease expense
980,000 US dollars
Loss on disposal of fixed assets
14,000 US dollars
Accounts receivable
0 US dollars
Other receivables
45,000 US dollars
Receivables from related parties
0 US dollars
Prepaid expenses and other current assets
negative 692,000 US dollars
Other non-current assets
0 US dollars
Accounts payable
3,829,000 US dollars
Accrued expenses
negative 9,756,000 US dollars
Operating lease liability
negative 1,112,000 US dollars
Investing activities
0 US dollars. No net cash provided or used.
Purchase of property and equipment
0 US dollars
Financing activities
77,067,000 US dollars. Net cash provided.
Proceeds from the issuance of debt
74,992,000 US dollars
Payment of fees associated with debt
0 US dollars
Proceeds from the exercise of stock options
2,075,000 US dollars
Operating adjustment reconciliation
81,651,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
77,067,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
0 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
0 US dollars
Ending cash on Jun 30, 2026
133,344,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
201,287,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
9,124,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
Not meaningful. Operating cash flow divided by reconciliation net income for the same period. The ratio is not meaningful when net income is zero or negative.
Operating cash flow
negative 67,943,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
0 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
negative 67,943,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net loss −$70.09M + net operating adjustments $2.15M = operating cash −$67.94M. The loss reduces the earnings basis of the reconciliation; it is not a cash payment. The signed loss remains a deduction at the operating reconciliation junction.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: negative 67,943,000 US dollars minus 0 US dollars equals negative 67,943,000 US dollars.
INHIBRX BIOSCIENCES, INC. (INBX) FY2026 YTD Q2 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!